Radiopharmaceuticals constitute a key component in the healthcare sector. BRIT produces and supplies a wide range of radiopharmaceuticals to hospitals and medical institutions to enable various diagnostic and therapeutic procedures in diseased patients. These radiopharmaceutical products undergo strict quality analysis and quality control tests, including sterility, pyrogen tests and biodistribution studies and are manufactured in strict compliance with regulations in India as per Indian Pharmacopoeia and Radiopharmaceutical Committee (RPC) guidelines.